The First Time We Tried to Define Our Company's Core Values, It Failed. Here's What We Did Differently the Second Time.

Thanks to the global COVID-19 vaccination drive and inelastic demand for healthcare, biotechnology stocks have been outperforming the broader markets so far this year. Because this trend will likely continue,...